Summary of Key Points Core Viewpoint - A total of 142 stocks reached their 52-week highs as of August 12, with notable performers including Yingmei Holdings (02028), Elite Group (01775), and Fuying Global Group (01620) achieving high rates of 164.89%, 84.78%, and 40.63% respectively [1]. Stock Performance - **Top Performers**: - Yingmei Holdings (02028) closed at 0.223 with a peak of 0.249, marking a 164.89% increase [1]. - Elite Group (01775) closed at 0.350 with a peak of 0.425, reflecting an 84.78% increase [1]. - Fuying Global Group (01620) closed at 0.180, reaching its peak at 0.180, showing a 40.63% increase [1]. - **Other Notable Stocks**: - Aoya Group (02425) increased by 34.36% [1]. - Fuyiy International Holdings (01470) saw a rise of 28.30% [1]. - Huajian Medical (01931) experienced a 27.58% increase [1]. 52-Week High Rankings - The ranking of stocks that reached their 52-week highs includes: - Yingmei Holdings (02028) at 164.89% [1]. - Elite Group (01775) at 84.78% [1]. - Fuying Global Group (01620) at 40.63% [1]. 52-Week Low Rankings - The report also highlights stocks that reached their 52-week lows, with notable declines including: - Jiadeng International Group (08153) at -15.25% [4]. - Kun Group (00924) at -12.86% [4]. - Zhongjia Guoxin (00899) at -10.00% [4].

Group 1 - The Hang Seng Index rose by 0.09%, gaining 22 points to close at 24,929 points, while the Hang Seng Tech Index fell by 0.39%. The morning trading volume in Hong Kong was HKD 110.2 billion [1] - Dairy stocks led the gains, with expectations that fertility subsidies will boost dairy product demand. Institutions noted that the meat and milk cycle is favorable for livestock companies. Notable stock performances include: Aoyuan Group up 35.62%, Modern Farming up 15%, and China Shengmu up 13% [1] - Hong Teng Precision (06088) saw a rise of over 7% due to the mass production ramp-up of its GB200 series products, while BYD Electronics (00285) increased by over 4% [1] - Zhonghui Biotechnology-B (02627) surged over 16% on its second day of trading, following a nearly 158% increase the previous day, with a total market capitalization exceeding HKD 15 billion [1] - Ping An Good Doctor (01833) rose by 5.6%, reporting significant achievements in its medical AI products and ongoing optimization of its business structure [1] - Huachen China (01114) increased by over 9%, with expected profit growth of 13% to 16% for the first half of the year [1] - Zhenjiu Lidu (06979) rose by over 8%, with institutions suggesting that policy variables are accelerating industry clearing, and performance bottoming is expected as early as the first half of next year [1] Group 2 - Lithium stocks fell in early trading, with strong expectations of a contraction in lithium supply. Analysts indicated that the overall demand increase for the second half of the year lacks imagination. Tianqi Lithium (09696) dropped by 8%, and Ganfeng Lithium (01772) fell by 5% [2]

Core Viewpoint - The stock price of Little Yellow Duck De Ying (02250) has surged over 70% in the past month, with a current increase of 15.6% to HKD 1.63, driven by a new service agreement with Kaan Limited for an AI-driven marketing intelligence and content automation system [1] Group 1 - Little Yellow Duck De Ying's stock price increased by over 15% in a single trading session, reaching a trading volume of HKD 9.7382 million [1] - The company announced a service agreement with Kaan Limited, which involves collaboration on the investment, development, and commercialization of an AI-driven marketing intelligence and content automation system [1] - The strategic value of the agreement includes transforming the company's intellectual property into AI-driven marketing solutions, opening new markets and revenue streams, while safeguarding core data assets and achieving significant financial benefits and competitive advantages [1]

Group 1 - The core point of the article is that 小黄鸭德盈 (Duckling DeYing) has seen a significant stock price increase of over 70% in the past month, with a current rise of 15.6% to HKD 1.63 [1] - The company announced a service agreement between its subsidiary, 森科产品有限公司 (Senke Products), and 科案有限公司 (Kean), focusing on the joint investment, development, and commercialization of an AI-driven marketing intelligence and content automation system [1] - The strategic value of this agreement includes transforming the company's intellectual property into AI-driven marketing/content solutions, opening new markets and revenue sources, while also safeguarding core data assets and achieving considerable financial benefits and competitive advantages [1]

2025年7月31日，港股上市公司小黄鸭德盈 （02250.HK）发布了《董事调任、变更首席财务官、公司秘书及授权代表、委任独立 非执行董事及变更董事会委员会组成》的公告。公告显示， 黄颍钊先生已辞任首席财务官；麦玉娇女士已辞任公司秘书及授权 代表；宋治强先生将由独立非执行董事调任为执行董事及获委任为首席财务官、公司秘书及授权代表，并将不再担任审核委员会 主席以及提名委员会与薪酬委员会成员；吴迪先生获委任为独立非执行董事、审核委员会主席及薪酬委员会成员；独立非执行董 事梁丙焄女士获委任为提名委员会成员。 据公告介绍，小黄鸭德盈新任执行董事及获委任为首席财务官、公司秘书及授权代表的宋治强先生曾于毕马威会计师事务所、罗 兵咸永道会计师事务所及德勤企业财务顾问有限公司任职。宋先生就担任执行董事、首席财务官及公司秘书有权收取每年合共 1,300,000港元的薪酬。 宋治强先生简历详细如下： 宋治强先生，50岁，于2021年12月20日获委任为独立非执行董事，并将于2025年8月1日起获调任为执行董事，同时出任首席财务 官、公司秘书及授权代表。宋先生于财务管理、会计税务、审计和企业融资方面拥有丰富经验，曾于毕马威会计师 ...

梁興超先生 獨立非執行董事： B.Duck Semk Holdings International Limited 小黃鴨德盈控股國際有限公司 （於開曼群島註冊成立的有限公司） （股份代號︰2250） 董事名單及其角色和職能 小黃鴨德盈控股國際有限公司之董事（「董事」）會（「董事會」）成員載 列如下： 執行董事： 許夏林先生 郭振傑先生 宋治強先生 呂行遠先生 非執行董事： 梁丙焄女士 陳嘉賢教授（太平紳士） 吳迪先生 董事會設有三個委員會。下表載列各董事會成員於該等委員會擔任的角色。 | | 董事會委員會 審核委員會 | 薪酬委員會 | 提名委員會 | | --- | --- | --- | --- | | 董事會成員 | | | | | 許夏林先生 | | 成員 | 主席 | | 梁丙焄女士 | 成員 | 主席 | 成員 | | 陳嘉賢教授（太平紳士） | 成員 | | 成員 | | 吳迪先生 | 主席 | 成員 | | 香港，2025年8月1日 ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年7月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 小黃鴨德盈控股國際有限公司 呈交日期: 2025年8月1日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 02250 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 2,000,000,000 | USD | | 0.000025 | USD | | 50,000 | | 增加 / 減少 (-) | | | | | | | USD | | | | 本月底結存 | | | 2,000,000,000 | USD | | 0.000025 | USD | | 50,000 | 本月底法定/註 ...

Performance Updates - 开拓药业-B (09939.HK) has completed patient enrollment for the Phase III clinical trial of KX-826 solution for androgenetic alopecia in adult males in China [2] - 李氏大药厂 (00950.HK) has received approval from the National Medical Products Administration for Socazolimab to be used in combination with chemotherapy for first-line treatment of extensive-stage small cell lung cancer in mainland China [2] - 恒瑞医药 (01276.HK) has received approval for clinical trials of SHR-8068 injection, Adebali monoclonal antibody injection, and Bevacizumab injection [2] - 恒瑞医药 (01276.HK) has also received approval to conduct clinical trials for HRS-5041, intended for prostate cancer treatment [2] - 深圳高速公路股份 (00548.HK) reported toll revenue of 106 million yuan for the outer ring project in June [2] - 大成生化科技 (00809.HK) has signed an EPC contract with Northeast Electric and Liaoning Electric for boiler renovation projects, with a maximum cost of 129.1 million yuan [2] - 小黄鸭德盈 (02250.HK) has signed a contract to develop an AI marketing system to diversify revenue sources [2] Buyback and Financing Activities - 威海银行 (09677.HK) plans to issue up to approximately 758 million domestic shares and 154 million H-shares, raising nearly 3 billion yuan [2] Financial Results - 香港电讯-SS (06823.HK) reported total revenue of 17.322 billion HKD for the first half, a year-on-year increase of 4%, with a net profit of 2.07 billion HKD, also up 4% [4] - 青岛银行 (03866.HK) reported operating revenue of 7.662 billion yuan for the first half, a growth of 7.5%, and a net profit of 3.065 billion yuan, up 16.05% [4] - 中国石油化工股份 (00386.HK) expects mid-term net profit to be between 20.1 billion and 21.6 billion yuan, a year-on-year decline of 39.5%-43.7% [4] - 汽车之家-S (02518.HK) reported total revenue of 3.212 billion yuan for the first half, a decrease of 7.75%, with a net profit of 772 million yuan, down 15.99% [4] - 绿茶集团 (06831.HK) issued a profit warning, expecting mid-term net profit to be between 230 million and 237 million yuan, a year-on-year increase of approximately 32%-36% [4] - 粤海置地 (00124.HK) issued a profit warning, expecting mid-term net profit to exceed 260 million HKD, turning from loss to profit [4] - 药师帮 (09885.HK) issued a profit warning, expecting mid-term net profit to exceed 70 million yuan [4] - 中国东方教育 (00667.HK) issued a profit warning, expecting mid-term net profit to grow by 45%-50% year-on-year [4] - 中核国际 (02302.HK) issued a profit warning, expecting mid-term revenue to increase to at least 585 million HKD, with net profit of at least 9.5 million HKD [4] - 大唐环境 (01272.HK) issued a profit warning, expecting mid-term net profit to decrease to between 350 million and 400 million yuan [4] - 长江生命科技 (00775.HK) issued a profit warning, expecting mid-term net loss of approximately 150 million HKD, turning from profit to loss year-on-year [4] - 延长石油国际 (00346.HK) issued a profit warning, expecting mid-term loss of approximately 27.9 million HKD [4]

智通财经APP讯，小黄鸭德盈(02250)发布公告，于2025年7月29日，公司间接全资附属公司森科产品有 限公司(森科产品)与科案有限公司(科案，连同森科产品，统称订约方)签订了一份服务协议。根据服务 协议，订约方已同意就共同投资、开发及商业化一项具备基于网页界面的人工智能(AI)驱动营销情报与 内容自动化系统(该项目)展开合作。 （原标题：小黄鸭德盈(02250)附属签约开发AI营销系统 拓新收益来源） 公告称，与科案签订服务协议将实现以下战略价值：透过将集团知识产权转化为 AI 驱动营销/内容解决 方案，开拓新市场及收益来源;同时保障核心数据资产，并获取可观的财务效益与竞争优势。 ...

小黄鸭德盈(02250)发布公告，自2025年8月1日起： 1.黄颍钊先生已辞任首席财务官; 3.宋治强先生将由独立非执行董事调任为执行董事及获委任为首席财务官、公司秘书及授权代表，并将 不再担任审核委员会主席以及提名委员会与薪酬委员会成员; 4.吴迪先生获委任为独立非执行董事、审核委员会主席及薪酬委员会成员;及 5.独立非执行董事梁丙焄女士获委任为提名委员会成员。 2.麦玉娇女士已辞任公司秘书及授权代表; ...